Human Umbilical Cord Blood Mononuclear Cells
1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Human Umbilical Cord Blood Mononuclear Cells are a mixture of various cell populations with a single nucleus, including hematopoietic and mesenchymal stem cells, endothelial progenitor cells, lymphocytes, and monocytes. Mononuclear cells of human umbilical cord blood have great proliferation potential and have been widely studied in regenerative medicine and immunoregulation in cell therapy. They can be induced to differentiate into neuron cells, osteoblasts, and lymphocytes.
Why choose Human Umbilical Cord Blood Mononuclear Cells from AcceGen?
Human Umbilical Cord Blood Mononuclear Cells are isolated from umbilical cord blood using AcceGen’s advanced technology. Cells are isolated by density gradient separation and cryopreserved immediately to ensure the best viability. Human Umbilical Cord Blood Mononuclear Cells are quality tested with less than 2% red blood cells.
Species | Human |
Cat.No | ABC-TC3844 |
Quality Control | All cell lots test negative for HIV-1, HBV, HCV, mycoplasma, yeast, fungi, and other pathogens. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | Mononuclear Cell |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Cord Blood |
Disease | Normal |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Cord Blood Cells |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
For research use only
Human Umbilical Cord Blood Mononuclear Cells provide a readily available source for studying mononuclear cell properties, regeneration capacity, and differentiation potential. Due to their outstanding regenerative capacity, umbilical cord blood mononuclear cells have been widely chosen as the primary source for transplantation in the treatment of nerve and vascular regeneration, such as brain injury/ischemic injury, myocardial infarction and other cell therapies. A variety of subpopulations of mononuclear cells can be isolated from our product for further differentiation and downstream research.